Newswise — October 3, 2019, Schaumburg, Illinois MicroVention, one of the world’s fastest growing medical device companies, has granted $250,000 to the Congress of Neurological Surgeons Foundation (CNS Foundation). This generous gift will fund educational programs dedicated toward the advancement of the field of endovascular education and technology.

“We have become extremely knowledgeable about how to treat and care for aneurysm and stroke patients. With that knowledge comes the responsibility to meet the demand which is higher than I’ve ever seen, due to the aging population,” said Elad I. Levy, MD, MBA, FACS, FAHA, Chair of the CNS Foundation. “MicroVention’s gift allows us to educate and expand the population of neurosurgeons who can skillfully serve our endovascular patients.”

“MicroVention’s gift and leadership are deeply appreciated by the CNS Foundation,” said Steven N. Kalkanis MD, 2020 CNS President. “This gift will allow the CNS Foundation to make a meaningful impact in neurosurgical education, particularly for endovascular surgeons. Our work with MicroVention is a terrific example of a philanthropic partnership that will allow the CNS Foundation meet to meet its mission to improve worldwide health.”


About the CNS Foundation The CNS Foundation’s philanthropic mission is to improve worldwide patient health by supporting innovative programs that allow neurosurgeons to collaborate globally as researchers, learners, educators and caregivers. Based in Schaumburg, Illinois, the three mission pillars are international philanthropy, clinical scientist career development and neurosurgical guidelines development, review and dissemination. The 2019 “Matched for the Mission” campaign will match all gifts from individuals and medical societies until the entire $1 million is matched. For more information about the CNS Foundation or to make your gift, please go to, or contact Courtney Johnson, Manager of Foundation & Giving, at [email protected].

About the Congress of Neurological Surgeons The Congress of Neurological Surgeons (CNS) is the global leader in neurosurgical education, serving to promote health by advancing neurosurgery through innovation and excellence in education. The CNS provides leadership in neurosurgery by inspiring and facilitating scientific discovery and its translation into clinical practice. The CNS maintains the vitality of the profession through volunteer efforts of its members and the development of leadership in service to the public, to colleagues in other disciplines, and to neurosurgeons throughout the world in all stages of their professional lives. For more information, visit

About MicroVention, Inc., A TERUMO Group Company. Terumo Corporation—MicroVention's parent company since 2006—has a long tradition of developing medical products of the highest standards. "Contributing to Society through Healthcare" is both Terumo's starting point and unchanging corporate mission. They fulfill that mission by providing a stable supply of the highest quality medical devices and services to patients and medical settings in over 160 countries.

Founded in 1921 with upwards of 20,000 employees worldwide, Terumo has three main business areas (Cardiac and Vascular Company, General Hospital Company, and Blood Management Company) with MicroVention falling under the Neurovascular Division of the Cardiac and Vascular Company.

To learn more about Terumo Corporation please visit their website,